Navigation Links
MedGenome to Present on OncoPept - a Point Solution in Cancer Immunotherapy at the Novel Immunotherapeutics Summit 2016

SAN FRANCISCO, January 12, 2016 /PRNewswire/ --

Our Analysis Reveals That Tongue and Buccal Cancers Harbor a set of Dual-purpose Tumor Neo-antigens That can be Used as Cancer Vaccines in a Therapeutic Setting, and as Biomarkers of Response to Select Patients for Cancer Immunotherapy

MedGenome will present results from their Head & Neck cancer study in which published genomics data from over 400 Head & Neck cancer samples have been analyzed to identify potential vaccine candidates using MedGenome's proprietary OncoPept platform at the Novel Immunotherapeutics Summit 2016, on January 25-26, 2016 at San Diego, CA .


The analysis shows that differential gene expression between tongue and buccal cancers produce both unique and shared vaccine candidates that can be used in combination therapies. Several studies have shown that the efficacy and durability of response to the checkpoint control inhibitors, which complement the traditional approach of targeting driver genes in cancer, are significantly enhanced by combining vaccine candidates derived from neo-antigens expressed by the tumor cells.

MedGenome's OncoPept is an integrated platform that uses exome sequencing, RNA sequencing and computational methods to characterize tumor neo-antigens, analyze T-cell neo-epitopes and reveal gene expression signatures. The platform has various pre-clinical and clinical research applications.

About MedGenome: 

MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual's genome. Our powerful genomics solutions accelerate drug discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome is the market leader for genetic diagnostic testing in India and has worked with thousands of doctors, hospitals, and patients across India by applying Next Generation Sequencing (NGS) techniques to large disease cohorts in cancer, eye and neurological disorders, diabetes, cardiovascular diseases and rare cancers.  

For more information, visit us at

Forward-looking Statements: 

This document contains certain forward-looking statements, other than the statements of research facts contained in this press release are forward looking statements. Terms such as  "believe", "estimate", "anticipate", "plan", "predict", "may", "hope", "can", "will", "should", "expect", "intend", "is designed to", "with the intent", "potential", the negative of these words or such other variations thereon or comparable terminology, may indicate forward-looking statements, but their absence does not mean that a statement is not forward-looking. These forward-looking statements speak only as of the date of this press release. The events and circumstances reflected in MedGenome's forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, MedGenome does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

For more details, contact:
Hiranjith GH
Director - Corporate Planning
MedGenome Labs Pvt. Ltd.

SOURCE MedGenome Labs Pvt. Ltd.
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Amarantus to Present at SeeThruEquity First Annual Microcap Healthcare Investor Conference
2. Insulet Corporation to Present at Upcoming Investor Conference
3. AMRI Date and Time Change for J.P. Morgan Healthcare Conference Presentation
4. GSI Group to Present at 18th Annual Needham Growth Conference on January 12, 2016
5. GSI Group to Present at CJS Securities Sixteenth Annual "New Ideas for the New Year" Investor Conference on January 13, 2016
6. Upcoming Corporate Presentations In San Francisco
7. Amgen To Present At The 34th Annual J.P. Morgan Healthcare Conference
8. MEDITE Cancer Diagnostics, Inc. will present at the SeeThruEquity Healthcare Investor Conference on January 11
9. inVentiv Health CEO to Present at J.P. Morgan Healthcare Conference
10. Intarcia Therapeutics Announces Upcoming Presentation at 34th Annual J.P. Morgan Healthcare Conference
11. Regeneron Announces Presentation at the 34th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
(Date:12/14/2019)... CHATTANOOGA, Tenn. (PRWEB) , ... December 13, 2019 ... ... Randall help patients suffering from gum disease in Chattanooga, TN receive ... disease treatment into their practice, Drs. Felts and Randall provide effective gum disease ...
(Date:12/9/2019)... ... December 09, 2019 , ... Medpricer™, which ... across purchased services contracts, today announced its latest partnership with San Diego-based Sharp ... with four acute care hospitals, three specialty hospitals, three affiliated medical groups, 22 ...
(Date:12/8/2019)... ... December 07, 2019 , ... ... medical affairs, regulatory, and technology-enabled solutions, announced that MAIA Pharmaceuticals, Inc. (MAIA), a ... products has chosen Soterius and its partners in Europe, to support their regulatory ...
Breaking Medicine Technology:
(Date:12/8/2019)... ... December 08, 2019 , ..., a ... Top 26 Logistics Degree Programs for 2020. The comprehensive research guide is based ... program is evaluated based on curriculum quality, graduation rate, reputation, and post-graduate employment. ...
(Date:12/6/2019)... ... 2019 , ... Connecticut is home to a growing healthcare ... On December 12th, Hartford Business Journal will recognize eight individuals and organizations who ... the Hartford Marriott. , “We are fortunate to have so many great providers ...
(Date:12/6/2019)... ... December 06, 2019 , ... COMPLIANCY GROUP is ... the Wyoming Medical Society. Compliancy Group is dedicated to educating and assisting Wyoming ... to adhere to the standards set forth by the Health Insurance Portability and ...
(Date:12/5/2019)... ... December 05, 2019 , ... A cohort of ... technology to help their patients more easily detect ruptured silicone gel implants. Dr. ... study and reporting on his experience. While the FDA currently recommends regular MRI ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... from launching exceptional products that help people embrace, achieve, and maintain a healthy ... never been more committed to our mission of impacting world health, so it’s ...
Breaking Medicine News(10 mins):